Site icon pharmaceutical daily

STADA on target for two bidders, one being private equitiy firm Cinven

STADA Arzneimittel building

STADA Arzneimittel building

German drugmaker Stada has confirmed certain rumours about receiving takeover offers from a private equity firm, Cinven Partners and one other unnamed bidder.

Stada said the takeover price is €56.00 per share.

STADA issued a press release saying it was weighing up its options to do what’s the best for the company.

“It is not yet possible to foresee whether a takeover offer from Cinven or the other potential bidder will indeed materialise. STADA will keep both the capital markets and the public updated on tangible development in this regard, in line with the applicable legal requirements,” Stada said.

Exit mobile version